BIBLIOGRAPHY
This new section of the site is dedicated to articles related to mesalamine, and provides detailed and analytical information for professional use.
These scientific documents focus primarily on its use, and cover specific areas such as medical studies, the latest clinical research and new advances taking place within the pharmaceutical industry.
If you cannot find a specific article in the chronological archives below, you can use the SEARCH box situated on the left hand column.
[Colorectal cancer in inflammatory bowel disease]
Tidsskr Nor Laegeforen 2007 Oct;127(20):2696-9
Clinical trial: randomized-controlled clinical study comparing the efficacy and safety of a low-volume vs. a high-volume mesalazine foam in active distal ulcerative colitis.
Aliment Pharmacol Ther 2007 Nov;26(9):1237-49
Review article: increasing the dose of oral mesalazine therapy for active ulcerative colitis does not improve remission rates.
Aliment Pharmacol Ther 2007 Nov;26(9):1179-86
Characterization of epithelial IL-8 response to inflammatory bowel disease mucosal E. coli and its inhibition by mesalamine.
Inflamm Bowel Dis 2007 Oct;(): [Epub ahead of print]
Exacerbation of ulcerative colitis after rituximab salvage therapy.
Inflamm Bowel Dis 2007 Nov;13(11):1365-8